Literature DB >> 23426163

Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia.

A M Aalbers, R T Calado, N S Young, C M Zwaan, C Wu, S Kajigaya, E A Coenen, A Baruchel, K Geleijns, V de Haas, G J L Kaspers, T W Kuijpers, D Reinhardt, J Trka, M Zimmermann, R Pieters, V H J van der Velden, M M van den Heuvel-Eibrink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23426163      PMCID： PMC4163790          DOI： 10.1038/leu.2013.57

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Extensive allelic variation and ultrashort telomeres in senescent human cells.

Authors:  Duncan M Baird; Jan Rowson; David Wynford-Thomas; David Kipling
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

2.  Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.

Authors:  T H Brümmendorf; T L Holyoake; N Rufer; M J Barnett; M Schulzer; C J Eaves; A C Eaves; P M Lansdorp
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

3.  Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.

Authors:  Rodrigo T Calado; Joshua A Regal; Mark Hills; William T Yewdell; Leandro F Dalmazzo; Marco A Zago; Peter M Lansdorp; Donna Hogge; Stephen J Chanock; Elihu H Estey; Roberto P Falcão; Neal S Young
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-15       Impact factor: 11.205

4.  Telomeric DNA in normal and leukemic blood cells.

Authors:  O Yamada; K Oshimi; T Motoji; H Mizoguchi
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

5.  Functional characterization of natural telomerase mutations found in patients with hematologic disorders.

Authors:  Zhong-Tao Xin; Adam D Beauchamp; Rodrigo T Calado; Jennifer W Bradford; Joshua A Regal; Aarthi Shenoy; Yuying Liang; Peter M Lansdorp; Neal S Young; Hinh Ly
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

6.  Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.

Authors:  Susan J J Swiggers; Marianne A Kuijpers; Maartje J M de Cort; H Berna Beverloo; J Mark J M Zijlmans
Journal:  Genes Chromosomes Cancer       Date:  2006-03       Impact factor: 5.006

7.  Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities.

Authors:  Ulrike Hartmann; Tim H Brümmendorf; Stefan Balabanov; Christian Thiede; Thomas Illme; Markus Schaich
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

Review 8.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

9.  Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.

Authors:  Göran Roos; Alexander Kröber; Pawel Grabowski; Dirk Kienle; Andreas Bühler; Hartmut Döhner; Richard Rosenquist; Stephan Stilgenbauer
Journal:  Blood       Date:  2007-11-28       Impact factor: 22.113

10.  Short telomeres are a risk factor for idiopathic pulmonary fibrosis.

Authors:  Jonathan K Alder; Julian J-L Chen; Lisa Lancaster; Sonye Danoff; Shu-chih Su; Joy D Cogan; Irma Vulto; Mingyi Xie; Xiaodong Qi; Rubin M Tuder; John A Phillips; Peter M Lansdorp; James E Loyd; Mary Y Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205
View more
  17 in total

1.  Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.

Authors:  Neha Nagpal; Jianing Wang; Jing Zeng; Emily Lo; Diane H Moon; Kevin Luk; Roman O Braun; Lauri M Burroughs; Sioban B Keel; Christopher Reilly; R Coleman Lindsley; Scot A Wolfe; Albert K Tai; Patrick Cahan; Daniel E Bauer; Yick W Fong; Suneet Agarwal
Journal:  Cell Stem Cell       Date:  2020-04-21       Impact factor: 24.633

2.  Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group.

Authors:  Robert B Gerbing; Todd A Alonzo; Lillian Sung; Alan S Gamis; Soheil Meshinchi; Sharon E Plon; Alison A Bertuch; Maria M Gramatges
Journal:  J Clin Oncol       Date:  2016-11-01       Impact factor: 44.544

Review 3.  Genomic instability is a principle pathologic feature of FLT3 ITD kinase activity in acute myeloid leukemia leading to clonal evolution and disease progression.

Authors:  Melanie T Rebechi; Keith W Pratz
Journal:  Leuk Lymphoma       Date:  2017-02-06

Review 4.  Maintenance of telomere length in AML.

Authors:  Peter M Lansdorp
Journal:  Blood Adv       Date:  2017-11-28

Review 5.  The Dual Role of ROS in Hematological Malignancies: Stem Cell Protection and Cancer Cell Metastasis.

Authors:  Azin Samimi; Mohammad Javad Khodayar; Hadis Alidadi; Elahe Khodadi
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

Review 6.  Biological and clinical implications of telomere dysfunction in myeloid malignancies.

Authors:  Ashwin Kishtagari; Justin Watts
Journal:  Ther Adv Hematol       Date:  2017-10-06

7.  Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy.

Authors:  Claudia Bruedigam; Frederik O Bagger; Florian H Heidel; Catherine Paine Kuhn; Solene Guignes; Axia Song; Rebecca Austin; Therese Vu; Erwin Lee; Sarbjit Riyat; Andrew S Moore; Richard B Lock; Lars Bullinger; Geoffrey R Hill; Scott A Armstrong; David A Williams; Steven W Lane
Journal:  Cell Stem Cell       Date:  2014-12-04       Impact factor: 24.633

8.  Telomerase reverse transcriptase (TERT) A1062T mutation as a prognostic factor in Egyptian patients with acute myeloid leukemia (AML).

Authors:  Salah Aref; Mohamed Sabry El-Ghonemy; Tarek Elsayed Abouzeid; Amr Mohamed El-Sabbagh; Mohamed Ali El-Baiomy
Journal:  Med Oncol       Date:  2014-08-10       Impact factor: 3.064

9.  Impact of telomere length on survival in classic and variant hairy cell leukemia.

Authors:  Evgeny Arons; Hong Zhou; Daniel C Edelman; Allison Gomez; Seth M Steinberg; David Petersen; Yonghong Wang; Paul S Meltzer; Robert J Kreitman
Journal:  Leuk Res       Date:  2015-09-24       Impact factor: 3.156

Review 10.  Chromosomal Instability in Acute Myeloid Leukemia.

Authors:  Mateus de Oliveira Lisboa; Paulo Roberto Slud Brofman; Ana Teresa Schmid-Braz; Aline Rangel-Pozzo; Sabine Mai
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.